Menu
Currency
GWAS Study

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.

Johansen CT, Wang J, Lanktree MB et al.

20657596 PubMed ID
GWAS Study Type
1660 Participants
52 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JC
Johansen CT
WJ
Wang J
LM
Lanktree MB
CH
Cao H
MA
McIntyre AD
BM
Ban MR
MR
Martins RA
KB
Kennedy BA
HR
Hassell RG
VM
Visser ME
SS
Schwartz SM
VB
Voight BF
ER
Elosua R
SV
Salomaa V
OC
O'Donnell CJ
DG
Dallinga-Thie GM
AS
Anand SS
YS
Yusuf S
HM
Huff MW
KS
Kathiresan S
HR
Hegele RA
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWAS) have identified multiple loci associated with plasma lipid concentrations. Common variants at these loci together explain <10% of variation in each lipid trait. Rare variants with large individual effects may also contribute to the heritability of lipid traits; however, the extent to which rare variants affect lipid phenotypes remains to be determined. Here we show an accumulation of rare variants, or a mutation skew, in GWAS-identified genes in individuals with hypertriglyceridemia (HTG). Through GWAS, we identified common variants in APOA5, GCKR, LPL and APOB associated with HTG. Resequencing of these genes revealed a significant burden of 154 rare missense or nonsense variants in 438 individuals with HTG, compared to 53 variants in 327 controls (P = 6.2 x 10(-8)), corresponding to a carrier frequency of 28.1% of affected individuals and 15.3% of controls (P = 2.6 x 10(-5)). Considering rare variants in these genes incrementally increased the proportion of genetic variation contributing to HTG.

463 European ancestry cases, 1,197 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1660
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.